International Stem Cell CORP Reports annual revenue of $7.8 million
Company Records $131.0 thousand loss
By USInMinutes
Published - Apr 01, 2024, 07:15 AM ET
Last Updated - Apr 01, 2024, 07:15 AM EDT
International Stem Cell CORP [ISCO] has reported $7.8 million in revenue for year ended Dec 31, 2023.
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $131.0 thousand.
